Publication | Closed Access
Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids
190
Citations
31
References
2020
Year
Elagolix with add-back therapy was effective in reducing heavy menstrual bleeding in women with uterine fibroids. (Funded by AbbVie; Elaris UF-1 and Elaris UF-2 ClinicalTrials.gov numbers, NCT02654054 and NCT02691494.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1